Abstract Body

Despite its continued high prevalence, genetic vulnerability to HIV-associated neurocognitive impairment (NCI) remains less well understood than in the general population. Risk factors for NCI (e.g., HIV replication, persistent inflammation) can induce the ubiquitous unfolded protein response (UPR), which activates initiator proteins that can phosphorylate eukaryotic translation initiation factor 2α (eIF2α) and subsequently, slow global translation initiation while selectively increasing translation of transcripts such as β-site amyloid precursor protein cleaving enzyme-1. Chronic UPR activation has been implicated in Alzheimer’s and Parkinson’s diseases. We evaluated associations of single nucleotide polymorphisms (SNPs) in the EIF2AK3 gene with neurocognitive (NC) performance of HIV+ adults.

1,047 participants from CHARTER’s Genome-Wide Association Study (GWAS) were randomly assigned 1:1 to either a Test set or a Validation set. Using a candidate gene approach, 3 SNPs in the EIF2AK3 gene (rs6739095, rs1913671, rs11684404) were compared to the Global Deficit Score (GDS) and Global NCI using routine univariate and multivariable methods to adjust for confounding conditions.

Median age was 43; 23% were women; 34% had European ancestry and 42% had African ancestry; 61% had AIDS; median CD4+ counts were 175 (nadir) and 428 (current); and 71% used antiretroviral therapy (ART) with 58% having plasma HIV RNA ≤ 50 c/mL. For rs6739095, 42% had ≥1 T allele; for rs1913671, 41% had ≥1 C allele; and for rs11684404, 39% had ≥1 C allele. Findings were similar in the Test and the Validation sets, e.g., rs11684404 was associated with GDS in a allelic dose manner (genotype-median GDS): CC-0.32, CT-0.37, TT-0.42 (p=0.032 (Test), 0.035 (Validation)). In the combined group, TT homozygotes had 46% higher risk of NCI than CC homozygotes (p=0.01). Associations of rs11684404 with either GDS or NCI persisted after multivariable adjustment (model p<0.0001). Those with non-European ancestry had stronger associations between these SNPs and GDS or NCI [e.g., 61% higher risk for rs11684404 TT than CC homozygotes (p=0.02)].

Variation in EIF2AK3 was associated with NC performance, with consistent effects in both test-validation and multivariable analyses, supporting the importance of UPR in HIV neuropathogenesis. EIF2AK3, and perhaps other UPR-related genes, may contribute to NCI risk in HIV+ adults.